Tushar Singh Barwal
Overview
Explore the profile of Tushar Singh Barwal including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
18
Citations
260
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Khandelwal A, Sharma U, Barwal T, Seam R, Gupta M, Rana M, et al.
Front Oncol
. 2021 Apr;
11:645475.
PMID: 33833996
Dysregulated expression profiles of microRNAs (miRNAs) have been observed in several types of cancer, including non-small cell lung cancer (NSCLC); however, the diagnostic and prognostic potential of circulating miRNAs in...
12.
Sharma U, Barwal T, Khandelwal A, Malhotra A, Rana M, Rana A, et al.
Biochimie
. 2021 Jan;
182:99-107.
PMID: 33429003
Triple-negative breast cancer (TNBC) is a highly aggressive subtype of breast cancer with fewer treatment options than other types of invasive breast cancer due to the loss of the estrogen,...
13.
Tuli H, Mittal S, Aggarwal D, Parashar G, Parashar N, Upadhyay S, et al.
Semin Cancer Biol
. 2020 Nov;
73:196-218.
PMID: 33130037
In the last few decades, targeting cancer by the use of dietary phytochemicals has gained enormous attention. The plausible reason and believe or mind set behind this fact is attributed...
14.
Sharma U, Barwal T, Acharya V, Singh K, Rana M, Singh S, et al.
Int J Mol Sci
. 2020 Sep;
21(18).
PMID: 32947897
Intrinsic resistance to ionizing radiation is the major impediment in the treatment and clinical management of esophageal squamous cell carcinoma (ESCC), leading to tumor relapse and poor prognosis. Although several...
15.
Barwal T, Sharma U, Vasquez K, Prakash H, Jain A
Biochimie
. 2020 Jul;
176:62-70.
PMID: 32634463
The early detection and diagnosis of cancer is critical to optimize the treatment and management of cancer patients. Typical methods such as imaging and tissue biopsy are invasive, time-consuming, and...
16.
Sharma U, Barwal T, Malhotra A, Pant N, Vivek , Dey D, et al.
Life Sci
. 2020 Jul;
257:118035.
PMID: 32622950
Despite the recent scientific advances made in cancer diagnostics and therapeutics, cancer still remains the second leading cause of death worldwide. Thus, there is a need to identify new potential...
17.
Aggarwal V, Tuli H, Tania M, Srivastava S, Ritzer E, Pandey A, et al.
Semin Cancer Biol
. 2020 May;
80:256-275.
PMID: 32461153
Epigallocatechin gallate (EGCG), also known as epigallocatechin-3-gallate, is an ester of epigallocatechin and gallic acid. EGCG, abundantly found in tea, is a polyphenolic flavonoid that has the potential to affect...
18.
Cancer Susceptibility Candidate 9 (CASC9): A Novel Targetable Long Noncoding RNA in Cancer Treatment
Sharma U, Barwal T, Acharya V, Tamang S, Vasquez K, Jain A
Transl Oncol
. 2020 May;
13(8):100774.
PMID: 32450549
Based on epidemiological data provided by the World Health Organization (2018), cancer is the second most prevalent cause of death worldwide. Several factors are thought to contribute to the high...